Home LiteratureArticle Details
PMID: 22872911 Published · ppublish English Journal Article

In photoinhibited photosystem II particles pheophytin photoreduction remains unimpaired.

FEBS letters ·Vol. 226 ·No. 1 ·1987-12-21 ·Pages 186-90

Allakhverdiev SI, Šetliková E, Klimov VV, Šetlik I

Abstract

Oxygen-evolving photosystem II particles (DT 20) isolated from pea chloroplasts by digitonin-Triton X-100 fractionation were photoinhibited with 150 W. m(-2) white light, at 20°C under three conditions: aerobic, anaerobic and strongly reducing (E(h) poised to approx. -250 mV with dithionite). Hill reaction rate (H (20) + BQ)and variable fluorescence (Fv) declined in parallel in all three cases with shortening half times: 30, 10 and 2.5 min, respectively. Light-induced absorbance changes at 685 nm characteristic of reversible photo accumulation of reduced pheophytin (& z -2.50 mV) remained essentially unchanged. We conclude that the three types of photoinhibitory treatment do not impair the separation of charges between chlorophyll P-680 and pheophytin in the photosystem II reaction center.

MeSH Terms
Aerobiosis Anaerobiosis Fluorescence Light Oxidation-Reduction Peas/metabolism,physiology,radiation effects Pheophytins/metabolism Photosystem II Protein Complex/metabolism Time Factors
Chemicals
Pheophytins Photosystem II Protein Complex
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Allakhverdiev S I
Institute of Soil Science and Photosynthesis, USSR Academy of Sciences, 142292 Pushchino, USSR.
Šetliková E
Klimov V V
Šetlik I
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
1987-12-21
Pages
186-90
Language
English
Region
England
NLM ID
0155157
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]